These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17873709)

  • 1. Increase in plasma concentration of amisulpride after addition of concomitant lithium.
    Bergemann N; Abu-Tair F; Kress KR; Parzer P; Kopitz J
    J Clin Psychopharmacol; 2007 Oct; 27(5):546-9. PubMed ID: 17873709
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia.
    Müller MJ; Regenbogen B; Härtter S; Eich FX; Hiemke C
    J Psychiatr Res; 2007 Oct; 41(8):673-9. PubMed ID: 16324716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amisulpride doses and plasma levels in different age groups of patients with schizophrenia or schizoaffective disorder.
    Müller MJ; Eich FX; Regenbogen B; Sachse J; Härtter S; Hiemke C
    J Psychopharmacol; 2009 May; 23(3):278-86. PubMed ID: 18562411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregabalin-associated increase of clozapine serum levels.
    Englisch S; Alm B; Meyer-Lindenberg A; Zink M
    J Clin Psychopharmacol; 2012 Feb; 32(1):127. PubMed ID: 22217943
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma amisulpride levels in schizophrenia or schizoaffective disorder.
    Bergemann N; Kopitz J; Kress KR; Frick A
    Eur Neuropsychopharmacol; 2004 May; 14(3):245-50. PubMed ID: 15056484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled study.
    Berwaerts J; Lane R; Nuamah IF; Lim P; Remmerie B; Hough DW
    J Affect Disord; 2011 Mar; 129(1-3):252-60. PubMed ID: 20947174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhabdomyolysis following dose increase of clozapine and combination therapy with lithium.
    Tseng KC; Hwang TJ
    J Clin Psychopharmacol; 2009 Aug; 29(4):398-9. PubMed ID: 19593187
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics and safety of combination therapy with lithium and risperidone.
    Demling JH; Huang ML; Remmerie B; Mannaert E; Sperling W
    Pharmacopsychiatry; 2006 Nov; 39(6):230-1. PubMed ID: 17124646
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome.
    Yasugi S; Garg V; Been G; Magoulas P
    Aust N Z J Psychiatry; 2010 Jun; 44(6):584. PubMed ID: 20482421
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.
    Cook B; Hoogenboom G
    Australas Psychiatry; 2004 Mar; 12(1):74-6. PubMed ID: 15715745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bipolar disorder.
    Belmaker RH
    N Engl J Med; 2004 Jul; 351(5):476-86. PubMed ID: 15282355
    [No Abstract]   [Full Text] [Related]  

  • 12. [The features of atypical neuroleptic amisulpride action].
    Grigor'eva EA; Ritskov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(6):59-64. PubMed ID: 15285638
    [No Abstract]   [Full Text] [Related]  

  • 13. Estimation of rac-amisulpride transfer into milk and of infant dose via milk during its use in a lactating woman with bipolar disorder and schizophrenia.
    Teoh S; Ilett KF; Hackett LP; Kohan R
    Breastfeed Med; 2011 Apr; 6(2):85-8. PubMed ID: 20925494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature.
    Zink M; Knopf U; Henn FA; Thome J
    Pharmacopsychiatry; 2004 Jan; 37(1):26-31. PubMed ID: 14750045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible skin rash in a bipolar disorder patient on first use of lithium.
    Wang EH; Yang AC
    Psychiatry Clin Neurosci; 2013 Jul; 67(5):365. PubMed ID: 23859668
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term use of 200 mg Dogmatil. Apropos of 13 cases].
    Planche R
    Sem Hop; 1984 Mar; 60(13):944-8. PubMed ID: 6144185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined treatment with amisulpride in patients with schizophrenia discharged from a short-term hospitalization unit: a 1-year retrospective study.
    Molina JD; Lerma-Carrillo I; Leonor M; Pascual F; Blasco-Fontecilla H; González-Parra S; López-Muñoz F; Alamo C
    Clin Neuropharmacol; 2009; 32(1):10-5. PubMed ID: 18978498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender aspects in the clinical treatment of schizophrenic inpatients with amisulpride: a therapeutic drug monitoring study.
    Müller MJ; Regenbogen B; Sachse J; Eich FX; Härtter S; Hiemke C
    Pharmacopsychiatry; 2006 Mar; 39(2):41-6. PubMed ID: 16555163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient hyperproinsulinemia during treatment with clozapine and amisulpride.
    Rettenbacher MA; Hummer M; Fleischhacker WW; Lechleitner M
    J Clin Psychiatry; 2004 Jun; 65(6):878-9. PubMed ID: 15291669
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperprolactinaemia with amisulpride.
    Ružić K; Grahovac T; Graovac M; Dadić-Hero E; Sepić-Grahovac D; Sabljić V
    Psychiatr Danub; 2011 Mar; 23(1):92-4. PubMed ID: 21448106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.